J&J Hit With $417M Verdict In 1st Calif. Talc Cancer Trial

Law360, Los Angeles (August 21, 2017, 1:24 PM EDT) -- The first California state jury to evaluate the possible link between Johnson & Johnson’s talcum powder products and ovarian cancer set a high-water mark on Monday with a $417 million verdict for the company’s role in causing a woman’s terminal cancer, surpassing large awards from earlier trials in Missouri.

The jury awarded plaintiff Eva Echeverria $70 million in compensatory damages and slapped J&J and its subsidiary and co-defendant Johnson & Johnson Consumer with $347 million in punitive damages. (AP) After two days of deliberations following the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.